Evidence map›Paper›PMID 39319704›Full record

ArticleBrain : a journal of neurology2025

BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis.

Caroline Gertrud Bergner, Franziska van der Meer, Jonas Franz, Aigli Vakrakou, Thea Würfel, Stefan Nessler, Lisa Schäfer, Cora Nau-Gietz, Anne Winkler, Nielsen Lagumersindez-Denis and 11 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Astrocyte CBJournal of neuroinflammation · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. BCAS1Nature reviews. Neurology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Caroline Gertrud BergnerDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Franziska van der MeerDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Jonas FranzDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Aigli VakrakouDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Thea WürfelDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Stefan NesslerDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Lisa SchäferDepartment of Neurology, University Hospital Leipzig, Leipzig 04103, Germany.ORCID 0000-0002-9714-9682
Cora Nau-GietzDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Anne WinklerDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Nielsen Lagumersindez-DenisDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Claudia WrzosDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Ioanna Alkmini DamkouInstitute of Neuronal Cell Biology, Technical University Munich, Munich 81377, Germany.
Christina SergiouDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Verena SchultzDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Carolin KnauerDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Imke MetzDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.ORCID 0000-0002-6571-7630
Erik BahnDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Enrique Garea RodriguezDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.
Doron MerklerDepartment of Pathology and Immunology, University of Geneva, Geneva 4 1211, Switzerland.ORCID 0000-0002-1792-1768
Mikael SimonsInstitute of Neuronal Cell Biology, Technical University Munich, Munich 81377, Germany.
Christine StadelmannDepartment of Neuropathology, University Medical Center Göttingen, Göttingen 37075, Germany.ORCID 0000-0003-1766-5458

Funding

Deutsche Forschungsgemeinschaft 408885537Deutschen Multiple Sklerose GesellschaftGemeinnützige Hertie-StiftungMinistry for Science and Culture of Lower SaxonyNational Multiple Sclerosis SocietyUniversity Medical Center Göttingen
6 · The paper itself

Abstract

Remyelination is a crucial regenerative process in demyelinating diseases, limiting persisting damage to the CNS. It restores saltatory nerve conduction and ensures trophic support of axons. In patients with multiple sclerosis, remyelination has been observed in both white and grey matter and found to be more efficient in the cortex. Brain-enriched myelin-associated protein 1 (BCAS1) identifies oligodendrocyte lineage cells in the stage of active myelin formation in development and regeneration. Other than in the white matter, BCAS1+ oligodendrocytes are maintained at high densities in the cortex throughout life. Here, we investigated cortical lesions in human biopsy and autopsy tissue from patients with multiple sclerosis in direct comparison to demyelinating mouse models and demonstrate that following a demyelinating insult BCAS1+ oligodendrocytes in remyelinating cortical lesions shift from a quiescent to an activated, internode-forming morphology co-expressing myelin-associated glycoprotein (MAG), necessary for axonal contact formation. Of note, activated BCAS1+ oligodendrocytes are found at early time points of experimental demyelination amidst ongoing inflammation. In human tissue, activated BCAS1+ oligodendrocytes correlate with the density of myeloid cells, further supporting their involvement in an immediate regenerative response. Furthermore, studying the microscopically normal appearing non demyelinated cortex in patients with chronic multiple sclerosis, we find a shift from quiescent BCAS1+ oligodendrocytes to mature, myelin-maintaining oligodendrocytes, suggesting oligodendrocyte differentiation and limited replenishment of BCAS1+ oligodendrocytes in long-standing disease. We also demonstrate that part of perineuronal satellite oligodendrocytes are BCAS1+ and contribute to remyelination in human and experimental cortical demyelination. In summary, our results provide evidence from human tissue and experimental models that BCAS1+ cells in the adult cortex represent a population of pre-differentiated oligodendrocytes that rapidly react after a demyelinating insult thus enabling immediate myelin regeneration. In addition, our data suggest that limited replenishment of BCAS1+ oligodendrocytes may contribute to the remyelination failure observed in the cortex in chronic multiple sclerosis.

Indexed as

Cerebral CortexMultiple SclerosisNerve Tissue ProteinsOligodendrogliaRemyelinationAdultAgedAnimalsDNA-Binding ProteinsFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedMyelin SheathDNA-Binding ProteinsMYT1 protein, humanNerve Tissue ProteinsTranscription Factorscortical remyelinationdemyelinationmultiple sclerosisoligodendrocytessatellite cells

Identifiers

PMID39319704
PMCPMC11884765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.